Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
REGN3 quarters
Position history for BlackRock Finance, Inc.'s holdings in REGENERON PHARMACEUTICALS
BlackRock Finance, Inc. holds 8.4M shares of REGN (REGENERON PHARMACEUTICALS), worth $8.9B as of 2024-Q2. The position was decreased (-1.4% shares). REGN represents 0.2% of BlackRock Finance, Inc.'s portfolio.
Current Value
$8.9B
Current Shares
8.4M
Total Value Change
+$1.3B
Total Shares Change
-183,341
Quarter-by-Quarter History
Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc.